A comprehensive view of U.S. Food and Drug Administration (FDA). This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA and USDA again confirm that country’s commercial milk supply is safe, amid recent string of bird flu cases in US dairy herds
Published: April 24, 2024 by Dairy Processing
FDA accepts for priority review GSK’s application for an expanded indication of Jemperli dostarlimab-gxly plus chemotherapy to include all adult patients with primary advanced or recurrent endometrial cancer
Published: April 24, 2024 by GSK Group (GlaxoSmithKline)
Bimatoprost found to be the most effective and only FDA-approved ingredient for eyelash serums shown to increase eyelash length safely, according to a review in the Journal of Cosmetic Dermatology
Published: April 22, 2024 by CosmeticsDesign.com (US)
FDA approves subcutaneous administration of Takeda’s ENTYVIO (vedolizumab) for maintenance therapy in moderately to severely active Crohn’s Disease
Published: April 19, 2024 by Business Wire
Vanda Pharmaceuticals thwarts a hostile takeover bid from Future Pak by implementing a shareholder rights plan or 'poison pill' strategy; the bid follows FDA approval for the expansion of its antipsychotic drug Fanapt
Published: April 19, 2024 by FiercePharma

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count